The American Heart Association is pleased to announced that our collaboration with Lawrence Livermore National Labs (LLNL) on the protein atlas developed through the AHA Center for Accelerated Discovery is being leveraged to help accelerate discovery of therapeutic antibodies or antiviral drugs for SARS-CoV-2, the virus that causes COVID-19.
Thanks to our novel innovation, Lawrence Livermore National Laboratory has launched a searchable data portal to share its COVID-19 research with scientists worldwide and the general public.
The portal houses a wealth of data LLNL scientists have gathered from their ongoing COVID-19 molecular design projects, particularly the computer-based “virtual” screening of interactions with SARS-CoV-2 viral proteins for drug design purposes.
The data is searchable so outside researchers can easily locate relevant data for their own work. The goal is to share these leading predictions with the research community to speed up the process of scientific discovery to combat the COVID-19 pandemic.
- Webinar replay: COVID-19 Update for Healthcare Professionals
- AHA COVID 19 compendium for professionals